Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies

Rudman, SM, Comins, C, Mukherji, D, Coffey, M, Mettinger, K, Protheroe, A, Harrington, KJ, Pandha, H and Spicer, JF (2009) Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies In: 45th Annual Meeting of the American-Society-of-Clinical-Oncology, 2009-05-29 - 2009-06-02, Orlando, FL.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (UNSPECIFIED)
Divisions :	Surrey research (other units)
Authors :	Name Email ORCID Rudman, SM Comins, C Mukherji, D Coffey, M Mettinger, K Protheroe, A Harrington, KJ Pandha, H h.pandha@surrey.ac.uk Spicer, JF
Date :	20 May 2009
Contributors :	Contribution Name Email ORCID publisher AMER SOC CLINICAL ONCOLOGY,
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Oncology, ONCOLOGY
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 09:30
Last Modified :	23 Jan 2020 15:36
URI:	http://epubs.surrey.ac.uk/id/eprint/824012

Actions (login required)

View Item

Downloads